POSB283 Approaches for Cost-Effectiveness Analyses in Adjuvant Oncology Indications and Their Acceptability By HTA Authorities
Jan 1, 2022, 00:00 AM
10.1016/j.jval.2021.11.885
https://www.valueinhealthjournal.com/article/S1098-3015(21)02680-2/fulltext
Section Title :
Section Order :
10416
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02680-2&doi=10.1016/j.jval.2021.11.885